0
June 1979, Vol 36, No. 6 >
Article | June 1979

Dagen des Oordeels: Title and subTitle BreakPathokinetic Mechanisms and Molecular Messengers (A Dramatic View)

W. King Engel, MD
[+] Author Affiliations

Accepted for publication Sept 15, 1978.

Reprint requests to Medical Neurology Branch, National Institute of Neurological and Communicative Disorders and Stroke, Bldg 10, Room 10D20, Bethesda, MD 20014 (Dr Engel).


Arch Neurol. 1979;36(6):329-339. doi:10.1001/archneur.1979.00500420039003
Text Size: A A A
Published online
Article
References
Comments

To stimulate creative thinking about, and further modeling of, pathokinetic mechanisms, two devices are used herein: personification, from the point of view of the muscle fiber, and juxtaposition of known or probable mechanisms with proposed possible mechanisms. Brutal terms dramatize the death of muscle fibers. "Assassinations" are imposed on the muscle fiber through mechanisms exogenous to the fiber; "suicides" are brought on by endogenous defects of the muscle fiber.

MECHANISMS AND EXAMPLES (CATEGORIZATION ARBITRARY) 

Assassination  Assassination, Direct, Simple.—Exogenous poisons, viruses, and protozoa of various sorts can affect muscle cells. They vary regarding specificity for skeletal muscle cells vs other cells. Poisons include bupivacaine,1 iodoacetate,2 20,25-diazacholesterol,3-6 2,4-dichlorophenoxyacetic acid,4,7-11 chlofibrate,12 perhexiline maleate,13 vincristine,14 and dinitrophenol.15-16 Myotrophic viruses include coxsackie virus, Theiler's mouse encephalomyelitis and Jungblut's SK virus,17 avian leukosis sarcoma virus (for avian muscle),15,18 and mouse C-particle-producing RNA tumor virus

REFERENCES

1 +
Hall-Craggs FCB:  Rapid regeneration of a whole skeletal muscle following treatment with bupivacaine . Exp Neurol 43:349-358, 1974;.
2 +
Brumback RA, Kula RW, Engel WK:  A model of defects in muscle glycogenolysis/glycolysis (GG/Gly) . J Neuropathol Exp Neurol 36:596, 1977;.
3 +
Brumback RA, Bertorini TE, Engel WK, et al:  A comparison of membrane-receptor agents in myotonia and fibrillation in vivo . Neurology 28:396, 1977;.
4 +
Peter JB, Campion DS:  Animal models of myotonia , in Rowland LP (ed): Pathogenesis of Human Muscular Dystrophies . Amsterdam, Excerpta Medica, 1977;, pp 739-746.
5 +
Winer N, Klachko DM, Baer RD, et al:  Myotonic response induced by inhibitary of cholesterol biosynthesis . Science 153:312-313, 1966;.
6 +
Reddy NM, Oliver KL, Engel WK:  Alterations in the sarcolemmal adenylate cyclase activity (AC-a) in myotonia . Neurology 27:378, 1977;.
7 +
Bryant SH, Morales-Aguilera A:  Chloride conductance in normal and myotonic muscle fibers and the action of monocarboxylic aromatic acids . J Physiol 219:357-383, 1971;.
8 +
Brody IA:  Myotonia induced by monocarboxylic aromatic acids: A possible mechanism . Arch Neurol 28:243-246, 1973;.
9 +
Kuhn E, Stein W:  Modell-myotonie nach 2,4-Dichlorphenoxyacetate bei der Ratte: Bestimmung des Glucose-6-phosphates, adenosintriphosphates und andenosindiphosphates im musculus pectoralis . Klin Wochenschr 42:1215-1216, 1964;.
10 +
Kuhn E, Stein W:  Modell myotonie nach 2,4-Dichlorphenoxyacetate (2,4-D) bei der Ratte. In vitro- und in vivo-untersuchungen uber den einfluss von 2,4-D auf den energiestoffwechsel des muskels . Klin Wochenschr 43:673-677, 1965;.
11 +
Eyzaguirre C, Folk B, Zeirler KL, et al:  Experimental myotonia and repetitive phenomena: The veratrinic effects of 2,4-dichlorphenoxyacetate (2,4-D) in the rat . Am J Physiol 155:169, 1948;.
12 +
Dromgoole SH, Campion DS, Peter JB:  Myotonia induced by clofibrate and sodium chlorophenoxy isobutyrate . Biochem Med 14:238-240, 1975;.
13 +
Lhermitte F, Fardeau M, Chedru F, et al:  Polyneuropathy after perhexiline maleate therapy . Br Med J 1:1256, 1976;.
14 +
Clark JT, Karpati G, Carpenter S, et al:  The effect of vincristine on skeletal muscle in the rat . J Neuropathol Exp Neurol 31:247-251, 1972;.
15 +
Askanas V, Engel WK: Multidimensional studies of diseased human tissue-cultured muscle investigating the pathogenesis of neuromuscular disorders, in Proceedings of the 11th World Congress of Neurology. Amsterdam, Excerpta Medica, to be published.
16 +
Melmed C, Karpati G, Carpenter S:  Experimental mitochondrial myopathy produced by in vivo uncoupling of oxidative phosphorylation . J Neurol Sci 26:305-318, 1975;.
17 +
Adams RD, Denny-Brown D, Pearson CM: Diseases of Muscle . New York, Harper and Row Publishers Inc, 1972;.
18 +
Engel WK, Askanas V:  Overlooked avian oncornavirus in cultured muscle—functionally significant . Science 192:1252-1253, 1976;.
19 +
Andrews JM, Gardner MB:  Lower motor neuron degeneration associated with type C RNA virus infection in mice-neuropathologic features . J Neuropathol Exp Neurol 33:285-289, 1974;.
20 +
Gardner MB, Rasheed S, Klement V:  Lower motor neuron disease in wild mice caused by indigenous type C virus and search for a similar etiology in human amyotrophic lateral sclerosis , in Andrews JM, Johnson RT, Brazier MAB, (eds): Amyotrophic Lateral Sclerosis, Recent Research Trends . New York, Academic Press Inc, 1976;, pp 217-234.
21 +
Andrews JM, Andrews RL:  The comparative neuropathology of motor neuron diseases , in Andrews JM, Johnson RT, Brazier MAB, (eds): Amyotrophic Lateral Sclerosis, Recent Research Trends . New York, Academic Press Inc, 1976;, pp 181-216.
22 +
Engel WK:  Diseases of the neuromuscular junction and muscle , in Adams C (ed): Neurohistochemistry . Amsterdam, Elsevier Publishing Co, 1965;, pp 622-672.
23 +
Jewetz E, Nelnick JL, Adelberg EA: Review of Medical Microbiology . Los Altos, Calif, Lange Medical Publications, 1976;.
24 +
Rowland LP, Greer M:  Toxoplasmic polymyositis . Neurology 11:367-370, 1961;.
25 +
Laranja FS, Dias E, Nobrega G, et al:  Chagas' disease: A clinical, epidemiologic, and pathologic study . Circulation 14:1035-1060, 1956;.
26 +
Dvorak JA, Howe CL:  The attraction of trypanosoma cruzi to vertebrate cells in vitro . J Protozool 23:534-537, 1976;.
27 +
Engel WK, Bishop DW, Cunningham GG:  Tubular aggregates in type II muscle fibers: Ultrastructural and histochemical correlation . J Ultrastruct Res 31:507-525, 1970;.
28 +
Engel WK:  Selective and nonselective susceptibility of muscle fiber types: A new approach to human neuromuscular diseases . Arch Neurol 22:97-117, 1970;.
29 +
Bender AN, Ringel SP, Engel WK, et al:  Myasthenia gravis: A serum factor blocking acetylcholine receptors of the human neuromuscular junction . Lancet 1:607-609, 1975;.
30 +
Ringel SP, Bender AN, Engel WK, et al:  Myasthenia gravis: Relationship between serum factor blocking acetylcholine receptors and antistriated-muscle antibody . Lancet 1:1388, 1975;.
31 +
Bender AN, Ringel Sp, Engel WK:  The acetylcholine receptor in normal and pathologic states: Immunoperoxidase visualization of alphabungarotoxin binding at a light and electronmicroscope level . Neurology 26:477-483, 1976;.
32 +
Engel WK:  Myasthenia gravis, corticosteroids, anticholinesterases . Ann NY Acad Sci 274:623-630, 1976;.
33 +
Engel AG, Tsujihata M, Lindstrom JM, et al:  The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis: A quantitative ultrastructural study . Ann NY Acad Sci 274:60-79, 1976;.
34 +
Engel AG, Lambert EH, Howard FM Jr:  Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis. Ultrastructural and light microscopic localization and electrophysiologic correlations . Mayo Clin Proc 52:267-280, 1977;.
35 +
Pinching AJ, Peters DK:  Remission of myasthenia gravis following plasma-exchange . Lancet 2:1373-1376, 1976;.
36 +
Finn R, Coates PM:  Plasma exchange in myasthenia gravis . Lancet 1:190-191, 1977;.
37 +
Dau PC, Lindstrom JM, Cassel CK, et al:  Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis . N Engl J Med 297:1134-1140, 1977;.
38 +
Engel WK, Shebert RT:  Fast-associated fatal rhabdomyolysis (familial) . Neurology 27:347-348, 1977;.
39 +
Engel WK, Trotter JL, McFarlin DE, et al:  Thymic epithelial cell contains acetylcholine receptor . Lancet 1:1310-1311, 1977;.
40 +
Adornato BT, Engel WK, Foidart-DeSalle M:  Elevations of hemopexin levels in neuromuscular disease . Arch Neurol 35:577-580, 1978;.
41 +
Engel WK, McFarlin DE:  Skeletal muscle pathology in myasthenia gravis-histological findings . Ann NY Acad Sci 135:68-78, 1966;.
42 +
Engel WK, Festoff BW, Patten BM, et al:  Myasthenia gravis . Ann Intern Med 81:225-246, 1974;.
43 +
Trotter JL, Engel WK, Ignaczak TF:  Amyloidosis with plasma cell dyscrasia . Arch Neurol 34:209-214, 1977;.
44 +
Glenner GG, Page DL:  Amyloid, amyloidosis, and amyloidogenesis . Int Rev Exp Pathol 15:1-92, 1976;.
45 +
Engel WK, Trotter JL, Askanas V:  Amyloid polyneuropathies. A parasparafucile molecule involved in its pathokinesis? , in Serratrice G (ed): IVèmes Journées Internationales de Pathologie Neuro-Musculaire de Marseille . Marseille, in press.
46 +
Victor M, Banker BP, Adams RD:  The neuropathy of multiple myeloma . J Neurol Neurosurg Psychiatry 21:73-88, 1958;.
47 +
Currie S, Henson RA, Morgan HG, et al:  The incidence of the non-metastatic neurological syndromes of obscure origin in the reticuloses . Brain 93:629-640, 1970;.
48 +
Dagan AD, Urich H, Gardner-Thorpe C:  Peripheral neuropathy and myeloma . J Neurol Sci 14:21-35, 1971;.
49 +
Whitaker JN, Sciabbarrasi J, Engel WK, et al:  Serum immunoglobulin and complement (C3) levels . Neurology 23:1164-1173, 1973;.
50 +
Engel WK, Askanas V:  Remote effects of focal cancer on the neuromuscular system , in Thompson FA, Green JR (eds): Advances in Neurology . New York, Raven Press, 1976;, pp 119-147.
51 +
Johnson RL, Fink CW, Ziff M:  Lymphotoxin formation by lymphocytes and muscle in polymyositis . J Clin Invest 51:2435-2449, 1972;.
52 +
Dawkins RL, Mastaglia FL:  Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression . N Engl J Med 288:434-438, 1973;.
53 +
Saunders M, Knowles M, Currie S:  Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders . J Neurol Neurosurg Psychiatry 32:569-571, 1969;.
54 +
Lisak RP, Zweiman B:  Mitogen and muscle extract induced in vitro proliferative responses in myasthenia gravis, dermatomyositis and polymyositis . J Neurol Neurosurg Psychiatry 38:521-524, 1975;.
55 +
Currie S, Saunders M, Nowles M, et al:  Immunological aspects of polymyositis. The in vitro activity of lymphocytes on incubation with muscle antigen and with muscle cultures . Q J Med 157:63-84, 1971;.
56 +
Engel WK:  Workshop on the aetiology of Duchenne muscular dystrophy: The vascular hypothesis , in Bradley WG, Gardner-Medwin D, Walton JN (eds): Recent Advances in Myology . New York, American Elsevier Publishing Co, 1975;, pp 166-177.
57 +
Engel WK:  Muscle biopsies in neuromuscular diseases : Pediatr Clin N Am 14:963-995, 1967;.
58 +
Pleasure DE, Walsh GP, Engel WK:  Atrophy of skeletal muscle in patients with Cushing's syndrome . Arch Neurol 22:118-125, 1970;.
59 +
Whitaker JN, Falchuck ZM, Engel WK, et al:  Hereditory sensory neuropathy . Arch Environ Health 28:359-371, 1974;.
60 +
Campa JF, Singer PA, Engel WK: The histochemical pathology of partially denervated cat muscles: Sequential changes during denervation and reinnervation, in Proceedings of the III International Congress on Muscle Diseases. Amsterdam, Excerpta Medica, 1974, p 77.
61 +
Engel WK: Histochemistry of neuromuscular disease-significance of muscle fiber types, in Proceedings of the VIII International Congress of Neurology, Vienna, Austria. Volume 2: Neuromuscular Diseases. Amsterdam, Excerpta Medica, 1965, pp 499-504.
62 +
Engel WK, Warmolts JR:  The motor unit: Diseases affecting it in toto or in portio , in Desmedt JE (ed): New Developments in Electromyography and Clinical Neurophysiology , Basel, Karger, 1973;, pp 141-177.
63 +
Askanas V, Engel WK:  Distinct subtypes of type I fibers of human skeletal muscle . Neurology 25:879-887, 1975;.
64 +
Engel WK:  Integrative histochemical approach to the defect of Duchenne muscular dystrophy , in Rowland LP (ed): Pathogenesis of the Human Muscular Dystrophies . New York, American Elsevier Publishing Co, 1977;, pp 277309.
65 +
Stalberg E, Ekstedt J:  Single fiber EMG and microphysiology of the motor unit in normal and diseased human muscle , in Desmedt JE (ed): New Developments in Electromyography and Clinical Neurophysiology . Basal, Karger, 1973;, pp 113-129.
66 +
Stalberg E, Theile B:  Discharge pattern of motoneurons in humans , in Desmedt JE (ed): New Developments in Electromyography and Clinical Neurophysiology . Basal, Karger, 1973;, vol 3, pp 234-241.
67 +
Edstedt J, Stalberg E:  Single fiber electromyography for the study of the microphysiology of the human muscle , in Desmedt JD (ed): New Developments in Electromyography and Clinical Neurophysiology . Basal, Karger, 1973;, vol 1, pp 89-112.
68 +
Stablerg E:  Electrogenesis in human dystrophic muscle , in Rowland LP (ed): Pathogenesis of Human Muscular Dystrophies . New York, Excerpta Medica, 1977;, pp 570-590.
69 +
Bertorini T, Stalberg E, Engel WK:  Histochemical and physiologic correlations in patients with type-I muscle fiber predominance (type II fiber paucity) . J Neuropathol Exp Neurol , to be published.
70 +
Engel WK:  A critique of congenital myopathies and other disorders , in Milhorat AT (ed): Exploratory Concepts in Muscular Dystrophy and Related Disorders . New York, Excerpta Medica, 1967;, pp 27-40.
71 +
Engel WK:  Central core disease and focal loss of cross-striation , in Goldensohn ES, Appel SH (eds): Scientific Approaches to Clinical Neurologi/ . Philadelphia, Lea & Febiger, 1978;, pp 1555-1571.
72 +
Resnick JS, Engel WK:  Target fibersstructural and cytochemical characteristics and their relationship to neurogenic muscle disease and fiber types , in Milhorat AT (ed): Exploratory Concepts in Muscular Dystrophy and Related Disorders . New York, Excerpta Medica, 1967;, pp 255-266.
73 +
Engel WK:  The essentiality of histo- and cytochemical studies of skeletal muscle in the investigation of neuromuscular disease . Neurology 12:778-794, 1962;.
74 +
Hamburger V:  Developmental history of the motor neuron . Neurosci Res Program Bull 15:1-37, 1976;.
75 +
Eng GD, Epstein BS, Engel WK, et al:  Malignant hyperthermia and central core disease in a child with congenital dislocating hips . Arch Neurol 35:189-197, 1978;.
76 +
Warmolts JR, Engel WK:  Open-biopsy electromyography . Arch Neurol 35:189-197, 1978;.
77 +
Warmolts JR, Engel WK:  Correlation of motor unit behavior with histochemical myofiber type in humans , in Desmedt JE (ed): New Developments in Electromyography and Clinical Neurophysiology . Basel, Karger, 1973;, pp 35-40.
78 +
Fenichel GM, Engel WK:  Histochemistry of muscle in infantile spinal muscular atrophy . Neurology 13:1059-1066, 1963;.
79 +
Engel WK, Borenstein A, DeVivo DC, et al:  High-single-dose alternate day prednisone (HSDAD-PRED) in treatment of the dermatomyositis/polymyositis complex . Trans Am Neurol Assoc 97:272-275, 1972;.
80 +
Denborough MA, Dennett A, Anderson RM:  Central-core disease and malignant hyperpyrexia . Br Med J 1:272-273, 1973;.
81 +
Moulds RFW, Denborough MA:  Biochemical basis of malignant hyperpyrexia . Br Med J 2:241-244, 1974;.
82 +
Isaacs H, Barlow MB:  Central core disease associated with elevated creatine phosphokinase levels: Two members of a family known to be susceptible to malignant hyperthermia . S Afr Med J 48:640, 1974;.
83 +
Reske-Neilsen E, Haase J, Kelstrup J:  Malignant hyperthermia in a family. The neurophysiological and light microscopical study of muscle biopsies of healthy members . Acta Pathol Microbiol Scand A 83:645-650, 1975;.
84 +
LaCour D, Juul-Jenson R, Reske-Neilsen E: Central and peripheral mechanisms in malignant hyperthermia, in Gordon RA, Britt BA, Kalow W (eds): International Symposium on Malignant Hyperthermia. Springfield, Ill, Charles C Thomas Publisher, 1973, pp 380-386.
85 +
Mendell JR, Engel WK, Derrer EC:  Duchenne muscular dystrophy: functional ischemia reproduces its characteristic lesions . Science 172:1143-1145, 1971;.
86 +
Mendell JR, Engel WK, Derrer EC:  Increased plasma enzyme concentrations in rats with functional ischemia of muscle provide a possible model of Duchenne muscular dystrophy . Nature 239:522-524, 1972;.
87 +
Engel WK, Hawley RJ:  Focal lesions of muscle in peripheral vascular disease: their comparison with Duchenne muscular dystrophy . Trans Am Neurol Assoc 101:240-242, 1976;.
88 +
Whitaker JN, Engel WK:  Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy . N Engl J Med 286:333-339, 1971;.
89 +
Whitaker JN, Engel WK:  Mechanisms of muscle injury in idiopathic inflammatory myopathy . N Engl J Med 289:107-108, 1973;.
90 +
Engel WK:  Duchenne muscular dystrophy: A histologically based ischemia hypothesis and comparison with experimental ischemia myopathy , in Pearson CM, Mustoffi FK (eds): The Striated Muscle . Baltimore, Williams & Wilkins Co, 1973;, pp 453-472.
91 +
Engel WK, Vick NA, Glueck CJ, et al:  A skeletal muscle disorder associated with intermittent symptoms and a possible defect of lipid metabolism . N Engl J Med 282:697-704, 1970;.
92 +
DiMauro S, DiMauro PMM, Mellis M:  Muscle carnitine palmityl transferase deficiency and myoglobinuria . Science 182:927-929, 1973;.
93 +
Kula R, Brumback R, Engel WK:  Ischemic contracture in muscle phosphorylase deficiency: Clinical scanning and histochemical and autoradiographic studies . Neurology 27:401-402, 1977;.
94 +
Brooks BR, Brumback RA, Rosenbaum RB, et al:  Triglyceride-mediated prevention of exercise-induced rhabdomyolysis in myophosphorylase deficiency . Neurology 27:379, 1977;.
95 +
Engel AG, Angelini C:  Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: A new syndrome . Science 179:899-901, 1973;.
96 +
Karpati G, Carpenter S, Engel AG, et al:  The syndrome of systemic carnitine deficiency: Clinical, morphologic, biochemical and pathophysiologic features . Neurology 25:16-24, 1975;.
97 +
DiMauro S, Eastwood AB:  Disorders of glycogen and lipid metabolism , in Griggs RC, Moxley RT III (eds): Advances in Neurology . New York, Raven Press, 1977;, pp 123-142.
98 +
Hers HG, Van Hoof F: Lysosomes and Storage Diseases . New York, Academic Press Inc, 1973;.
99 +
Hudgson P, Gardner-Medwin D, Worsfold M, et al:  Adult myopathy from glycogen storage diseases . Brain 91:435-460, 1968;.
100 +
Engel AG:  Acid maltase deficiency in adults: Studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies . Brain 93:599-616, 1970;.
101 +
Askanas V, Engel WK, DiMauro S, et al:  Adult-onset acid maltase deficiency . N Engl J Med 294:573-578, 1976;.
102 +
Askanas V, Engel WK:  Diseased human muscle in tissue culture: A new approach to the pathogenesis of human neuromuscular disorders , in Rowland LP (ed): Pathogenesis of the Human Muscular Dystrophies . New York, American Elsevier Publishing Co, 1977;, pp 856-871.
103 +
deDuve C:  Exploring cells with a centrifuge . Science 189:186-194, 1975;.
104 +
Askanas V, Engel WK, Ringel SP, et al:  Acetylcholine receptors of aneurally cultured human and animal muscle . Neurology 27:1019-1022, 1977;.
105 +
Askanas V, Engel WK:  Reovirus-like particles in cultured muscle fibers of a patient with a chronic vacuolar myopathy . Neurology 28:386, 1978;.
106 +
Engel WK:  Investigative approach to the muscular dystrophies , in Griggs RC (ed): Advances and Treatment of the Neuromuscular Diseases . New York, Raven Press, 1977;, pp 197-226.
107 +
Engel WK:  Muscle fiber hypotrophy with central nuclei , in Goldensohn ES, Appel SH (eds): Scientific Approaches to Clinical Neurology . Philadelphia, Lea & Febiger, 1978;, pp 1572-1601.
108 +
Ringel SP, Engel WK, Bender AN:  Extrajunctional acetylcholine receptors on myogenously de-innervated muscle fibers . J Histochem Cytochem 24:1033-1041, 1976;.
109 +
Ringel SP, Bender AN, Engel WK:  Extrajunctional acetylcholine receptors: Alterations in human and experimental neuromuscular diseases . Arch Neurol 33:751-758, 1976;.
110 +
Patrick J, Lindstrom J:  Autoimmune response to acetylcholine receptor . Science 180:871-878, 1973;.
111 +
Lindstrom JM, Einarson BL, Lennon VA, et al:  Pathological mechanisms in experimental autoimmune myasthenia gravis: I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and anti-body-receptor complexes from muscles of rats with experimental autoimmune myasthenia gravis . J Exp Med 144:726-738, 1976;.
112 +
Lindstrom JM, Engel AG, Seybold ME, et al:  Pathological mechanisms in autoimmune myasthenia gravis: II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies . J Exp Med 144:739-753, 1976;.
113 +
Lennon VA:  Immunology of the acetylcholine receptor . Immunol Commun 5:323-344, 1976;.
114 +
Trotter JL, Ringel SP, Cook JD, et al:  Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis . Neurology 27:1120-1124, 1977;.
115 +
Ringel SP, Bender AN, Festoff BW, et al:  Ultrastructural demonstration and analytical application of extrajunctional receptors of denervated human and rat skeletal muscle fibers . Nature 255:730-731, 1975;.
116 +
Engel WK, Brooke MH:  Histochemistry of the myotonic disorders , in Kuhn E (ed): Progressive Muskeldystrophie, Myotonie, Myasthenie . Heidelberg, Springer-Verlag, 1966;, pp 203-222.
117 +
Goldberg AL, Odessey R:  Regulation of protein and amino acid degradation in skeletal muscle , in Milhorat AT (ed): Exploratory Concepts in Muscular Dystrophy . Amsterdam, Excerpta Medica, 1974;, vol 2, pp 187-199.
118 +
Askanas V, Engel WK, Reddy NB, et al:  X-linked recessive congenital muscle fiber hypertrophy with central nuclei: Abnormalities of growth and adenylate cyclase in cultured muscle . Arch Neurol , to be published.
119 +
Engel WK, Gold GN, Karpati G:  Type I fiber hypotrophy and central nuclei: A rare congenital muscle abnormality with a possible experimental mode . Arch Neurol 18:435-444, 1968;.
120 +
Coërs C, Woolf AL: Innervation of Muscle—A Biopsy Study . Oxford, England, Blackwell Scientific Publications, 1959;.
121 +
Wochner RD, Drews G, Strober W, et al:  Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: A hereditary error of immunoglobulin catabolism . J Clin Invest 45:321-329, 1966;.
122 +
Engel WK, McFarlin DE, Drews G, et al:  Protein abnormalities in neuromuscular diseases: Part I . JAMA 195:754-760, 1966;.
123 +
Engel WK, McFarlin DE, Drews G, et al:  Protein abnormalities in neuromuscular diseases: II . JAMA 195:837-842, 1966;.
124 +
Huff TA, LeBovitz HE:  Dynamics of insulin secretion in myotonic dystrophy . J Clin Endocrinol 28:992-998, 1968;.
125 +
Huff TA, Horton ES, LeBovitz HE:  Abnormal insulin secretion in myotonic dystrophy . N Engl J Med 277:837-841, 1967;.
126 +
Gordon P, Griggs RC, Nissley SP, et al:  Studies of plasma insulin in myotonic dystrophy . J Clin Endocrinol Metab 29:684-690, 1969;.
127 +
Daniel PM, Strich SJ:  Abnormalities in the musclespindles in dystrophia myotonica . Neurology 14:310-316, 1964;.
128 +
Swash M, Fox KP:  The pathology of the human muscle spindle: Effect of denervation . J Neurol Sci 22:124, 1974;.
129 +
Kucera J:  Splitting of the nuclear bag fibers in the course of muscle spindle denervation and reinnervation . J Histochem Cytochem 25:1102-1104, 1977;.
130 +
Kucera J:  Intrafusal muscle fiber histochemistry following its motor reinnervation . J Histochem Cytochem 25:1260-1263, 1977;.
131 +
Goldberg AL, Griffin GE, Dice JF Jr:  Regulation of protein turnover in normal and dystrophic muscle , in Rowland LP (ed): Pathogenesis of Human Muscular Dystrophies . Amsterdam, Excerpta Medica, 1977;, pp 376-385.
132 +
Cahill GF Jr:  Starvation in man . N Engl J Med 282:668-670, 1970;.
133 +
Cahill GF Jr, Aoki TT, Brennan MF, et al:  Insulin and muscle amino acid balance . Proc Nutr Soc 31:233-234, 1972;.
134 +
Cahill GF Jr, Aoki TT, Marliss EB:  Endocrine pancreas , in Handbook of Physiology, Endocrinology . Washington, DC, American Physiological Society, 1972;, pp 563-592.
135 +
Felig P, Wahren J:  Protein turnover and amino acid metabolism in the regulation of gluconeogenesis . Fed Proc 33:1092-1098, 1975;.
136 +
Dyken PR, Harper PS:  Congenital dystrophica myotonica . Neurology 23:465-473, 1973;.
137 +
Karpati G, Carpenter S, Watters GV, et al:  Infantile myotonic dystrophy. Histochemical and electron microscopic features in skeletal muscle . Neurology 23:1066-1077, 1973;.
138 +
Felig P:  Amino acid metabolism in man . Ann Rev Biochem 44:933-955, 1975;.
139 +
Chang TW, Goldberg AL:  The origin of alanine produced in skeletal muscle . J Biol Chem 253:3677-3684, 1978;.
140 +
Chang TW, Goldberg AL:  The metabolic fates of amino acids and the formation of glutamino in skeletal muscle . J Biol Chem 253:3685-3692, 1978;.
141 +
Chang TW, Goldberg AL:  Leucine inhibits oxidation of glucose and pyruvate in skeletal muscles during fasting . J Biol Chem 3696-3701, 1978;.
142 +
Lehninger A:  Dynamics and mechanisms of active ion transport across the mitocondrial membrane . Ann Ny Acad Sci 137:700-736, 1966;.
143 +
Lehninger A:  Mitochondria and Ca++ ion transport . Biochem J 119:129-138, 1970;.
144 +
Lehninger A, Carafoli E, Rossi C:  Energy linked ion movements in mitochondrial systems . Adv Enzymol 29:259-320, 1967;.
145 +
Linn ECC:  Glycerol utilization and its regulation in mammals . Ann Rev Biochem 46:765-795, 1977;.
146 +
Oberc MA, Engel WK:  Ultrastructural localization of calcium in normal and abnormal skeletal muscle . Lab Invest 36:566-577, 1977;.
147 +
Langer A:  Events at the cardiac sarcolemma location and movement of contractile-dependent calcium . Fed Proc 35:1274-1278, 1976;.
148 +
Hadju S, Leonard EJ:  A calcium transport system for mammalian cells . Life Sci 17:1527-1534, 1975;.
149 +
Schwartz A:  Cell membrane Na-, K+ATPase and sarcoplasmic reticulum: Possible regulators of intracellular ion activity . Fed Proc 35:1279-1282, 1976;.
150 +
Siegel BA, Engel WK, Derrer EC:  Localization of 99mTc-diphosphonate in acutely injured muscle: Relationship to muscle calcium deposition . Neurology 25:1055-1058, 1975;.
151 +
Siegel BA, Engel WK, Derrer EC:  Localization of technetium 99mdiphosphonate in acutely injured muscle . Neurology 27:230-238, 1977;.
152 +
Brumback RA, Bertorini TE, Engel WK, et al:  The effect of pharmacologic acetylcholine receptor blockade on fibrilation and myotonic in rat skeletal muscle . Arch Neurol 35:8-10, 1978;.
153 +
Kula R, Line BR, Siegel BA, et al:  99mTc-diphosphonate scanning of soft-tissue in neuromuscular diseases . Neurology 26:370, 1976;.
154 +
Askanas V:  Identification of the agent responsible for the abnormal immunoelectrophoretic pattern of serum in Duchenne's progressive muscular dystrophy . Life Sci 5:1767-1773, 1966;.
155 +
Askanas V:  Immunoelectrophoretic study of sera of patients with Duchenne's progressive muscular dystrophy . Neurol Neurochir Pol 1:141-146, 1967;.
156 +
Askanas V, Engel WK:  Chick muscle in tissue culture: The ubiquity of viral infection . Acta Neuropathol 32:271-279, 1975;.
157 +
Askanas V, Engel WK, Britton DE, et al:  Reincarnation in cultured muscle of mitochondrial abnormalities from two patients with epilepsy and lactic-acidosis . Arch Neurol , to be published.
158 +
Askanas V, Mazurczak J:  The serum immunoelectrophoretic test in patients with Duchenne's progressive muscular dystrophy . Life Sci 5:247-251, 1966;.
159 +
Danieli GA, Angelini C:  Duchenne carrier detection . Lancet 2:90, 1976;.
160 +
Danieli GA, Angelini C:  Duchenne carrier detection . Lancet 2:415, 1976;.
161 +
Carafoli E:  The transport of Ca++ by mitochondria. Problems and perspectives . Biochemie 55:755-762, 1973;.
162 +
Carafoli E, Patriarcha P, Rossi CS:  A comparative study of the role of mitochondria and the sarcoplasmic reticulum in the uptake and release of Ca++ by the rat diaphragm . J Cell Physiol 74:17-30, 1969;.
163 +
Jacobus WE, Tiozzo R, Lugli G, et al:  Aspects of energy-linked calcium accumulation by rat heart mitochondria . J Biol Chem 250:7863-7870, 1975;.
164 +
Meissner G:  ATP and Ca+ + binding by the Ca++ pump protein of sarcoplasmic reticulum . Biochim Biophys Acta 298:906-926, 1973;.
165 +
Bianchi CP:  Cell calcium and malignant hyperthermia , in Gordon RA, Britt BA, Kalow W (eds): Malignant Hyperthermia . Springfield, Ill, Charles C Thomas Publisher, 1973;, pp 147-151.
166 +
Moore L, Chen T, Knapp HR, et al:  Energy-dependent calcium sequestration activity in rat liver microsomes . J Biol Chem 250:4562-4568, 1975;.
167 +
Yu BP, Masoro EJ, Morley TF:  Analysis of the arrangement of protein components in the sarcoplasmic reticulum of rat skeletal muscle . J Biol Chem 251:2037-2043, 1976;.
168 +
MacLennan DH:  Components of the calcium transport system of sarcoplasmic reticulum , in Gordon RA, Britt BA, Kalow W (eds): Malignant Hyperthermia . Springfield, Ill, Charles C Thomas Publisher, 1976;, pp 139-146.
169 +
Gilbert DS, Newley BJ, Anderton BH:  Neurofilament disguise, destruction and discipline . Nature 256:586, 1975;.
170 +
Reddy MK, Etlinger JD, Rabinowitz M, et al:  Removal of Z-lines and α-actinin from isolated myofibrils by a calcium-activated neutral protease . J Biol Chem 250:4278-4284.
171 +
Reville WJ, Goll DE, Stromer MH, et al:  A Ca++-activated protease possibly involved in myofibrillar protein turnover: Subcellular localization of the protease in porcine skeletal muscle . J Cell Biol 70:1-8, 1976;.
172 +
Roobel A, Alleyne GAO:  A study of stabilization of glucoeogenic activity in rat live slices by calcium and manganese ions . Biochem J 129:231-239, 1972;.
173 +
Gazitt Y, Ohad J, Layter A:  Changes in phospholipid susceptibility toward phospholypases in ATP depletion in avian and amphibian erythrocyte membranes . Biochim Biophys Acta 382:65-72, 1975;.
174 +
Nicholson G, Paste A:  The cancer cell: Dynamic aspects and modifications in cellsurface organization . N Engl J Med 295:197-203, 1976;.
175 +
Hinkley RE, Green LS:  Effects of halothane and colchicine on microtubules and electrical activity of rabbit vagus nerves . J Neurobiol 2:97, 1971;.
176 +
Samson FE, Hinkley RE:  Neuronal microtubular systems (editorial views) . Anesthesiology 36:417, 1972;.
177 +
Schlaepfer W, Bingg R:  High Ca++ solution for Wallerian degeneration . J Cell Biol 59:456, 1973;.
178 +
Darzynkiewicz A, Traganos F, Sharpless T, et al:  DNA denaturation in situ . J Cell Biol 68:1-10, 1976;.
179 +
Comings DE, Harris DC:  Nuclear proteins: I. Electrophoretic comparison of mouse nucleoli, heterochromatin, euchromatin and contractile proteins . Exp Cell Res 96:161-179, 1975;.
180 +
Engel WK, Cunningham GG:  Alkaline phosphatase-positive abnormal muscle fibers of humans . J Histochem Cytochem 18:55-57, 1970;.
181 +
Hawley RJ, Engel WK:  Focal lesions of muscle in peripheral vascular disease: Their comparison with Duchenne muscular dystrophy . Trans Am Neurol Assoc 101:240-242, 1976;.
182 +
Gordon RA, Britt BA, Kalow W: Malignant Hyperthermia . Springfield, Ill, Charles C Thomas Publisher, 1973;.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

1 +
Hall-Craggs FCB:  Rapid regeneration of a whole skeletal muscle following treatment with bupivacaine . Exp Neurol 43:349-358, 1974;.
2 +
Brumback RA, Kula RW, Engel WK:  A model of defects in muscle glycogenolysis/glycolysis (GG/Gly) . J Neuropathol Exp Neurol 36:596, 1977;.
3 +
Brumback RA, Bertorini TE, Engel WK, et al:  A comparison of membrane-receptor agents in myotonia and fibrillation in vivo . Neurology 28:396, 1977;.
4 +
Peter JB, Campion DS:  Animal models of myotonia , in Rowland LP (ed): Pathogenesis of Human Muscular Dystrophies . Amsterdam, Excerpta Medica, 1977;, pp 739-746.
5 +
Winer N, Klachko DM, Baer RD, et al:  Myotonic response induced by inhibitary of cholesterol biosynthesis . Science 153:312-313, 1966;.
6 +
Reddy NM, Oliver KL, Engel WK:  Alterations in the sarcolemmal adenylate cyclase activity (AC-a) in myotonia . Neurology 27:378, 1977;.
7 +
Bryant SH, Morales-Aguilera A:  Chloride conductance in normal and myotonic muscle fibers and the action of monocarboxylic aromatic acids . J Physiol 219:357-383, 1971;.
8 +
Brody IA:  Myotonia induced by monocarboxylic aromatic acids: A possible mechanism . Arch Neurol 28:243-246, 1973;.
9 +
Kuhn E, Stein W:  Modell-myotonie nach 2,4-Dichlorphenoxyacetate bei der Ratte: Bestimmung des Glucose-6-phosphates, adenosintriphosphates und andenosindiphosphates im musculus pectoralis . Klin Wochenschr 42:1215-1216, 1964;.
10 +
Kuhn E, Stein W:  Modell myotonie nach 2,4-Dichlorphenoxyacetate (2,4-D) bei der Ratte. In vitro- und in vivo-untersuchungen uber den einfluss von 2,4-D auf den energiestoffwechsel des muskels . Klin Wochenschr 43:673-677, 1965;.
11 +
Eyzaguirre C, Folk B, Zeirler KL, et al:  Experimental myotonia and repetitive phenomena: The veratrinic effects of 2,4-dichlorphenoxyacetate (2,4-D) in the rat . Am J Physiol 155:169, 1948;.
12 +
Dromgoole SH, Campion DS, Peter JB:  Myotonia induced by clofibrate and sodium chlorophenoxy isobutyrate . Biochem Med 14:238-240, 1975;.
13 +
Lhermitte F, Fardeau M, Chedru F, et al:  Polyneuropathy after perhexiline maleate therapy . Br Med J 1:1256, 1976;.
14 +
Clark JT, Karpati G, Carpenter S, et al:  The effect of vincristine on skeletal muscle in the rat . J Neuropathol Exp Neurol 31:247-251, 1972;.
15 +
Askanas V, Engel WK: Multidimensional studies of diseased human tissue-cultured muscle investigating the pathogenesis of neuromuscular disorders, in Proceedings of the 11th World Congress of Neurology. Amsterdam, Excerpta Medica, to be published.
16 +
Melmed C, Karpati G, Carpenter S:  Experimental mitochondrial myopathy produced by in vivo uncoupling of oxidative phosphorylation . J Neurol Sci 26:305-318, 1975;.
17 +
Adams RD, Denny-Brown D, Pearson CM: Diseases of Muscle . New York, Harper and Row Publishers Inc, 1972;.
18 +
Engel WK, Askanas V:  Overlooked avian oncornavirus in cultured muscle—functionally significant . Science 192:1252-1253, 1976;.
19 +
Andrews JM, Gardner MB:  Lower motor neuron degeneration associated with type C RNA virus infection in mice-neuropathologic features . J Neuropathol Exp Neurol 33:285-289, 1974;.
20 +
Gardner MB, Rasheed S, Klement V:  Lower motor neuron disease in wild mice caused by indigenous type C virus and search for a similar etiology in human amyotrophic lateral sclerosis , in Andrews JM, Johnson RT, Brazier MAB, (eds): Amyotrophic Lateral Sclerosis, Recent Research Trends . New York, Academic Press Inc, 1976;, pp 217-234.
21 +
Andrews JM, Andrews RL:  The comparative neuropathology of motor neuron diseases , in Andrews JM, Johnson RT, Brazier MAB, (eds): Amyotrophic Lateral Sclerosis, Recent Research Trends . New York, Academic Press Inc, 1976;, pp 181-216.
22 +
Engel WK:  Diseases of the neuromuscular junction and muscle , in Adams C (ed): Neurohistochemistry . Amsterdam, Elsevier Publishing Co, 1965;, pp 622-672.
23 +
Jewetz E, Nelnick JL, Adelberg EA: Review of Medical Microbiology . Los Altos, Calif, Lange Medical Publications, 1976;.
24 +
Rowland LP, Greer M:  Toxoplasmic polymyositis . Neurology 11:367-370, 1961;.
25 +
Laranja FS, Dias E, Nobrega G, et al:  Chagas' disease: A clinical, epidemiologic, and pathologic study . Circulation 14:1035-1060, 1956;.
26 +
Dvorak JA, Howe CL:  The attraction of trypanosoma cruzi to vertebrate cells in vitro . J Protozool 23:534-537, 1976;.
27 +
Engel WK, Bishop DW, Cunningham GG:  Tubular aggregates in type II muscle fibers: Ultrastructural and histochemical correlation . J Ultrastruct Res 31:507-525, 1970;.
28 +
Engel WK:  Selective and nonselective susceptibility of muscle fiber types: A new approach to human neuromuscular diseases . Arch Neurol 22:97-117, 1970;.
29 +
Bender AN, Ringel SP, Engel WK, et al:  Myasthenia gravis: A serum factor blocking acetylcholine receptors of the human neuromuscular junction . Lancet 1:607-609, 1975;.
30 +
Ringel SP, Bender AN, Engel WK, et al:  Myasthenia gravis: Relationship between serum factor blocking acetylcholine receptors and antistriated-muscle antibody . Lancet 1:1388, 1975;.
31 +
Bender AN, Ringel Sp, Engel WK:  The acetylcholine receptor in normal and pathologic states: Immunoperoxidase visualization of alphabungarotoxin binding at a light and electronmicroscope level . Neurology 26:477-483, 1976;.
32 +
Engel WK:  Myasthenia gravis, corticosteroids, anticholinesterases . Ann NY Acad Sci 274:623-630, 1976;.
33 +
Engel AG, Tsujihata M, Lindstrom JM, et al:  The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis: A quantitative ultrastructural study . Ann NY Acad Sci 274:60-79, 1976;.
34 +
Engel AG, Lambert EH, Howard FM Jr:  Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis. Ultrastructural and light microscopic localization and electrophysiologic correlations . Mayo Clin Proc 52:267-280, 1977;.
35 +
Pinching AJ, Peters DK:  Remission of myasthenia gravis following plasma-exchange . Lancet 2:1373-1376, 1976;.
36 +
Finn R, Coates PM:  Plasma exchange in myasthenia gravis . Lancet 1:190-191, 1977;.
37 +
Dau PC, Lindstrom JM, Cassel CK, et al:  Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis . N Engl J Med 297:1134-1140, 1977;.
38 +
Engel WK, Shebert RT:  Fast-associated fatal rhabdomyolysis (familial) . Neurology 27:347-348, 1977;.
39 +
Engel WK, Trotter JL, McFarlin DE, et al:  Thymic epithelial cell contains acetylcholine receptor . Lancet 1:1310-1311, 1977;.
40 +
Adornato BT, Engel WK, Foidart-DeSalle M:  Elevations of hemopexin levels in neuromuscular disease . Arch Neurol 35:577-580, 1978;.
41 +
Engel WK, McFarlin DE:  Skeletal muscle pathology in myasthenia gravis-histological findings . Ann NY Acad Sci 135:68-78, 1966;.
42 +
Engel WK, Festoff BW, Patten BM, et al:  Myasthenia gravis . Ann Intern Med 81:225-246, 1974;.
43 +
Trotter JL, Engel WK, Ignaczak TF:  Amyloidosis with plasma cell dyscrasia . Arch Neurol 34:209-214, 1977;.
44 +
Glenner GG, Page DL:  Amyloid, amyloidosis, and amyloidogenesis . Int Rev Exp Pathol 15:1-92, 1976;.
45 +
Engel WK, Trotter JL, Askanas V:  Amyloid polyneuropathies. A parasparafucile molecule involved in its pathokinesis? , in Serratrice G (ed): IVèmes Journées Internationales de Pathologie Neuro-Musculaire de Marseille . Marseille, in press.
46 +
Victor M, Banker BP, Adams RD:  The neuropathy of multiple myeloma . J Neurol Neurosurg Psychiatry 21:73-88, 1958;.
47 +
Currie S, Henson RA, Morgan HG, et al:  The incidence of the non-metastatic neurological syndromes of obscure origin in the reticuloses . Brain 93:629-640, 1970;.
48 +
Dagan AD, Urich H, Gardner-Thorpe C:  Peripheral neuropathy and myeloma . J Neurol Sci 14:21-35, 1971;.
49 +
Whitaker JN, Sciabbarrasi J, Engel WK, et al:  Serum immunoglobulin and complement (C3) levels . Neurology 23:1164-1173, 1973;.
50 +
Engel WK, Askanas V:  Remote effects of focal cancer on the neuromuscular system , in Thompson FA, Green JR (eds): Advances in Neurology . New York, Raven Press, 1976;, pp 119-147.
51 +
Johnson RL, Fink CW, Ziff M:  Lymphotoxin formation by lymphocytes and muscle in polymyositis . J Clin Invest 51:2435-2449, 1972;.
52 +
Dawkins RL, Mastaglia FL:  Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression . N Engl J Med 288:434-438, 1973;.
53 +
Saunders M, Knowles M, Currie S:  Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders . J Neurol Neurosurg Psychiatry 32:569-571, 1969;.
54 +
Lisak RP, Zweiman B:  Mitogen and muscle extract induced in vitro proliferative responses in myasthenia gravis, dermatomyositis and polymyositis . J Neurol Neurosurg Psychiatry 38:521-524, 1975;.
55 +
Currie S, Saunders M, Nowles M, et al:  Immunological aspects of polymyositis. The in vitro activity of lymphocytes on incubation with muscle antigen and with muscle cultures . Q J Med 157:63-84, 1971;.
56 +
Engel WK:  Workshop on the aetiology of Duchenne muscular dystrophy: The vascular hypothesis , in Bradley WG, Gardner-Medwin D, Walton JN (eds): Recent Advances in Myology . New York, American Elsevier Publishing Co, 1975;, pp 166-177.
57 +
Engel WK:  Muscle biopsies in neuromuscular diseases : Pediatr Clin N Am 14:963-995, 1967;.
58 +
Pleasure DE, Walsh GP, Engel WK:  Atrophy of skeletal muscle in patients with Cushing's syndrome . Arch Neurol 22:118-125, 1970;.
59 +
Whitaker JN, Falchuck ZM, Engel WK, et al:  Hereditory sensory neuropathy . Arch Environ Health 28:359-371, 1974;.
60 +
Campa JF, Singer PA, Engel WK: The histochemical pathology of partially denervated cat muscles: Sequential changes during denervation and reinnervation, in Proceedings of the III International Congress on Muscle Diseases. Amsterdam, Excerpta Medica, 1974, p 77.
61 +
Engel WK: Histochemistry of neuromuscular disease-significance of muscle fiber types, in Proceedings of the VIII International Congress of Neurology, Vienna, Austria. Volume 2: Neuromuscular Diseases. Amsterdam, Excerpta Medica, 1965, pp 499-504.
62 +
Engel WK, Warmolts JR:  The motor unit: Diseases affecting it in toto or in portio , in Desmedt JE (ed): New Developments in Electromyography and Clinical Neurophysiology , Basel, Karger, 1973;, pp 141-177.
63 +
Askanas V, Engel WK:  Distinct subtypes of type I fibers of human skeletal muscle . Neurology 25:879-887, 1975;.
64 +
Engel WK:  Integrative histochemical approach to the defect of Duchenne muscular dystrophy , in Rowland LP (ed): Pathogenesis of the Human Muscular Dystrophies . New York, American Elsevier Publishing Co, 1977;, pp 277309.
65 +
Stalberg E, Ekstedt J:  Single fiber EMG and microphysiology of the motor unit in normal and diseased human muscle , in Desmedt JE (ed): New Developments in Electromyography and Clinical Neurophysiology . Basal, Karger, 1973;, pp 113-129.
66 +
Stalberg E, Theile B:  Discharge pattern of motoneurons in humans , in Desmedt JE (ed): New Developments in Electromyography and Clinical Neurophysiology . Basal, Karger, 1973;, vol 3, pp 234-241.
67 +
Edstedt J, Stalberg E:  Single fiber electromyography for the study of the microphysiology of the human muscle , in Desmedt JD (ed): New Developments in Electromyography and Clinical Neurophysiology . Basal, Karger, 1973;, vol 1, pp 89-112.
68 +
Stablerg E:  Electrogenesis in human dystrophic muscle , in Rowland LP (ed): Pathogenesis of Human Muscular Dystrophies . New York, Excerpta Medica, 1977;, pp 570-590.
69 +
Bertorini T, Stalberg E, Engel WK:  Histochemical and physiologic correlations in patients with type-I muscle fiber predominance (type II fiber paucity) . J Neuropathol Exp Neurol , to be published.
70 +
Engel WK:  A critique of congenital myopathies and other disorders , in Milhorat AT (ed): Exploratory Concepts in Muscular Dystrophy and Related Disorders . New York, Excerpta Medica, 1967;, pp 27-40.
71 +
Engel WK:  Central core disease and focal loss of cross-striation , in Goldensohn ES, Appel SH (eds): Scientific Approaches to Clinical Neurologi/ . Philadelphia, Lea & Febiger, 1978;, pp 1555-1571.
72 +
Resnick JS, Engel WK:  Target fibersstructural and cytochemical characteristics and their relationship to neurogenic muscle disease and fiber types , in Milhorat AT (ed): Exploratory Concepts in Muscular Dystrophy and Related Disorders . New York, Excerpta Medica, 1967;, pp 255-266.
73 +
Engel WK:  The essentiality of histo- and cytochemical studies of skeletal muscle in the investigation of neuromuscular disease . Neurology 12:778-794, 1962;.
74 +
Hamburger V:  Developmental history of the motor neuron . Neurosci Res Program Bull 15:1-37, 1976;.
75 +
Eng GD, Epstein BS, Engel WK, et al:  Malignant hyperthermia and central core disease in a child with congenital dislocating hips . Arch Neurol 35:189-197, 1978;.
76 +
Warmolts JR, Engel WK:  Open-biopsy electromyography . Arch Neurol 35:189-197, 1978;.
77 +
Warmolts JR, Engel WK:  Correlation of motor unit behavior with histochemical myofiber type in humans , in Desmedt JE (ed): New Developments in Electromyography and Clinical Neurophysiology . Basel, Karger, 1973;, pp 35-40.
78 +
Fenichel GM, Engel WK:  Histochemistry of muscle in infantile spinal muscular atrophy . Neurology 13:1059-1066, 1963;.
79 +
Engel WK, Borenstein A, DeVivo DC, et al:  High-single-dose alternate day prednisone (HSDAD-PRED) in treatment of the dermatomyositis/polymyositis complex . Trans Am Neurol Assoc 97:272-275, 1972;.
80 +
Denborough MA, Dennett A, Anderson RM:  Central-core disease and malignant hyperpyrexia . Br Med J 1:272-273, 1973;.
81 +
Moulds RFW, Denborough MA:  Biochemical basis of malignant hyperpyrexia . Br Med J 2:241-244, 1974;.
82 +
Isaacs H, Barlow MB:  Central core disease associated with elevated creatine phosphokinase levels: Two members of a family known to be susceptible to malignant hyperthermia . S Afr Med J 48:640, 1974;.
83 +
Reske-Neilsen E, Haase J, Kelstrup J:  Malignant hyperthermia in a family. The neurophysiological and light microscopical study of muscle biopsies of healthy members . Acta Pathol Microbiol Scand A 83:645-650, 1975;.
84 +
LaCour D, Juul-Jenson R, Reske-Neilsen E: Central and peripheral mechanisms in malignant hyperthermia, in Gordon RA, Britt BA, Kalow W (eds): International Symposium on Malignant Hyperthermia. Springfield, Ill, Charles C Thomas Publisher, 1973, pp 380-386.
85 +
Mendell JR, Engel WK, Derrer EC:  Duchenne muscular dystrophy: functional ischemia reproduces its characteristic lesions . Science 172:1143-1145, 1971;.
86 +
Mendell JR, Engel WK, Derrer EC:  Increased plasma enzyme concentrations in rats with functional ischemia of muscle provide a possible model of Duchenne muscular dystrophy . Nature 239:522-524, 1972;.
87 +
Engel WK, Hawley RJ:  Focal lesions of muscle in peripheral vascular disease: their comparison with Duchenne muscular dystrophy . Trans Am Neurol Assoc 101:240-242, 1976;.
88 +
Whitaker JN, Engel WK:  Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy . N Engl J Med 286:333-339, 1971;.
89 +
Whitaker JN, Engel WK:  Mechanisms of muscle injury in idiopathic inflammatory myopathy . N Engl J Med 289:107-108, 1973;.
90 +
Engel WK:  Duchenne muscular dystrophy: A histologically based ischemia hypothesis and comparison with experimental ischemia myopathy , in Pearson CM, Mustoffi FK (eds): The Striated Muscle . Baltimore, Williams & Wilkins Co, 1973;, pp 453-472.
91 +
Engel WK, Vick NA, Glueck CJ, et al:  A skeletal muscle disorder associated with intermittent symptoms and a possible defect of lipid metabolism . N Engl J Med 282:697-704, 1970;.
92 +
DiMauro S, DiMauro PMM, Mellis M:  Muscle carnitine palmityl transferase deficiency and myoglobinuria . Science 182:927-929, 1973;.
93 +
Kula R, Brumback R, Engel WK:  Ischemic contracture in muscle phosphorylase deficiency: Clinical scanning and histochemical and autoradiographic studies . Neurology 27:401-402, 1977;.
94 +
Brooks BR, Brumback RA, Rosenbaum RB, et al:  Triglyceride-mediated prevention of exercise-induced rhabdomyolysis in myophosphorylase deficiency . Neurology 27:379, 1977;.
95 +
Engel AG, Angelini C:  Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: A new syndrome . Science 179:899-901, 1973;.
96 +
Karpati G, Carpenter S, Engel AG, et al:  The syndrome of systemic carnitine deficiency: Clinical, morphologic, biochemical and pathophysiologic features . Neurology 25:16-24, 1975;.
97 +
DiMauro S, Eastwood AB:  Disorders of glycogen and lipid metabolism , in Griggs RC, Moxley RT III (eds): Advances in Neurology . New York, Raven Press, 1977;, pp 123-142.
98 +
Hers HG, Van Hoof F: Lysosomes and Storage Diseases . New York, Academic Press Inc, 1973;.
99 +
Hudgson P, Gardner-Medwin D, Worsfold M, et al:  Adult myopathy from glycogen storage diseases . Brain 91:435-460, 1968;.
100 +
Engel AG:  Acid maltase deficiency in adults: Studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies . Brain 93:599-616, 1970;.
101 +
Askanas V, Engel WK, DiMauro S, et al:  Adult-onset acid maltase deficiency . N Engl J Med 294:573-578, 1976;.
102 +
Askanas V, Engel WK:  Diseased human muscle in tissue culture: A new approach to the pathogenesis of human neuromuscular disorders , in Rowland LP (ed): Pathogenesis of the Human Muscular Dystrophies . New York, American Elsevier Publishing Co, 1977;, pp 856-871.
103 +
deDuve C:  Exploring cells with a centrifuge . Science 189:186-194, 1975;.
104 +
Askanas V, Engel WK, Ringel SP, et al:  Acetylcholine receptors of aneurally cultured human and animal muscle . Neurology 27:1019-1022, 1977;.
105 +
Askanas V, Engel WK:  Reovirus-like particles in cultured muscle fibers of a patient with a chronic vacuolar myopathy . Neurology 28:386, 1978;.
106 +
Engel WK:  Investigative approach to the muscular dystrophies , in Griggs RC (ed): Advances and Treatment of the Neuromuscular Diseases . New York, Raven Press, 1977;, pp 197-226.
107 +
Engel WK:  Muscle fiber hypotrophy with central nuclei , in Goldensohn ES, Appel SH (eds): Scientific Approaches to Clinical Neurology . Philadelphia, Lea & Febiger, 1978;, pp 1572-1601.
108 +
Ringel SP, Engel WK, Bender AN:  Extrajunctional acetylcholine receptors on myogenously de-innervated muscle fibers . J Histochem Cytochem 24:1033-1041, 1976;.
109 +
Ringel SP, Bender AN, Engel WK:  Extrajunctional acetylcholine receptors: Alterations in human and experimental neuromuscular diseases . Arch Neurol 33:751-758, 1976;.
110 +
Patrick J, Lindstrom J:  Autoimmune response to acetylcholine receptor . Science 180:871-878, 1973;.
111 +
Lindstrom JM, Einarson BL, Lennon VA, et al:  Pathological mechanisms in experimental autoimmune myasthenia gravis: I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and anti-body-receptor complexes from muscles of rats with experimental autoimmune myasthenia gravis . J Exp Med 144:726-738, 1976;.
112 +
Lindstrom JM, Engel AG, Seybold ME, et al:  Pathological mechanisms in autoimmune myasthenia gravis: II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies . J Exp Med 144:739-753, 1976;.
113 +
Lennon VA:  Immunology of the acetylcholine receptor . Immunol Commun 5:323-344, 1976;.
114 +
Trotter JL, Ringel SP, Cook JD, et al:  Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis . Neurology 27:1120-1124, 1977;.
115 +
Ringel SP, Bender AN, Festoff BW, et al:  Ultrastructural demonstration and analytical application of extrajunctional receptors of denervated human and rat skeletal muscle fibers . Nature 255:730-731, 1975;.
116 +
Engel WK, Brooke MH:  Histochemistry of the myotonic disorders , in Kuhn E (ed): Progressive Muskeldystrophie, Myotonie, Myasthenie . Heidelberg, Springer-Verlag, 1966;, pp 203-222.
117 +
Goldberg AL, Odessey R:  Regulation of protein and amino acid degradation in skeletal muscle , in Milhorat AT (ed): Exploratory Concepts in Muscular Dystrophy . Amsterdam, Excerpta Medica, 1974;, vol 2, pp 187-199.
118 +
Askanas V, Engel WK, Reddy NB, et al:  X-linked recessive congenital muscle fiber hypertrophy with central nuclei: Abnormalities of growth and adenylate cyclase in cultured muscle . Arch Neurol , to be published.
119 +
Engel WK, Gold GN, Karpati G:  Type I fiber hypotrophy and central nuclei: A rare congenital muscle abnormality with a possible experimental mode . Arch Neurol 18:435-444, 1968;.
120 +
Coërs C, Woolf AL: Innervation of Muscle—A Biopsy Study . Oxford, England, Blackwell Scientific Publications, 1959;.
121 +
Wochner RD, Drews G, Strober W, et al:  Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: A hereditary error of immunoglobulin catabolism . J Clin Invest 45:321-329, 1966;.
122 +
Engel WK, McFarlin DE, Drews G, et al:  Protein abnormalities in neuromuscular diseases: Part I . JAMA 195:754-760, 1966;.
123 +
Engel WK, McFarlin DE, Drews G, et al:  Protein abnormalities in neuromuscular diseases: II . JAMA 195:837-842, 1966;.
124 +
Huff TA, LeBovitz HE:  Dynamics of insulin secretion in myotonic dystrophy . J Clin Endocrinol 28:992-998, 1968;.
125 +
Huff TA, Horton ES, LeBovitz HE:  Abnormal insulin secretion in myotonic dystrophy . N Engl J Med 277:837-841, 1967;.
126 +
Gordon P, Griggs RC, Nissley SP, et al:  Studies of plasma insulin in myotonic dystrophy . J Clin Endocrinol Metab 29:684-690, 1969;.
127 +
Daniel PM, Strich SJ:  Abnormalities in the musclespindles in dystrophia myotonica . Neurology 14:310-316, 1964;.
128 +
Swash M, Fox KP:  The pathology of the human muscle spindle: Effect of denervation . J Neurol Sci 22:124, 1974;.
129 +
Kucera J:  Splitting of the nuclear bag fibers in the course of muscle spindle denervation and reinnervation . J Histochem Cytochem 25:1102-1104, 1977;.
130 +
Kucera J:  Intrafusal muscle fiber histochemistry following its motor reinnervation . J Histochem Cytochem 25:1260-1263, 1977;.
131 +
Goldberg AL, Griffin GE, Dice JF Jr:  Regulation of protein turnover in normal and dystrophic muscle , in Rowland LP (ed): Pathogenesis of Human Muscular Dystrophies . Amsterdam, Excerpta Medica, 1977;, pp 376-385.
132 +
Cahill GF Jr:  Starvation in man . N Engl J Med 282:668-670, 1970;.
133 +
Cahill GF Jr, Aoki TT, Brennan MF, et al:  Insulin and muscle amino acid balance . Proc Nutr Soc 31:233-234, 1972;.
134 +
Cahill GF Jr, Aoki TT, Marliss EB:  Endocrine pancreas , in Handbook of Physiology, Endocrinology . Washington, DC, American Physiological Society, 1972;, pp 563-592.
135 +
Felig P, Wahren J:  Protein turnover and amino acid metabolism in the regulation of gluconeogenesis . Fed Proc 33:1092-1098, 1975;.
136 +
Dyken PR, Harper PS:  Congenital dystrophica myotonica . Neurology 23:465-473, 1973;.
137 +
Karpati G, Carpenter S, Watters GV, et al:  Infantile myotonic dystrophy. Histochemical and electron microscopic features in skeletal muscle . Neurology 23:1066-1077, 1973;.
138 +
Felig P:  Amino acid metabolism in man . Ann Rev Biochem 44:933-955, 1975;.
139 +
Chang TW, Goldberg AL:  The origin of alanine produced in skeletal muscle . J Biol Chem 253:3677-3684, 1978;.
140 +
Chang TW, Goldberg AL:  The metabolic fates of amino acids and the formation of glutamino in skeletal muscle . J Biol Chem 253:3685-3692, 1978;.
141 +
Chang TW, Goldberg AL:  Leucine inhibits oxidation of glucose and pyruvate in skeletal muscles during fasting . J Biol Chem 3696-3701, 1978;.
142 +
Lehninger A:  Dynamics and mechanisms of active ion transport across the mitocondrial membrane . Ann Ny Acad Sci 137:700-736, 1966;.
143 +
Lehninger A:  Mitochondria and Ca++ ion transport . Biochem J 119:129-138, 1970;.
144 +
Lehninger A, Carafoli E, Rossi C:  Energy linked ion movements in mitochondrial systems . Adv Enzymol 29:259-320, 1967;.
145 +
Linn ECC:  Glycerol utilization and its regulation in mammals . Ann Rev Biochem 46:765-795, 1977;.
146 +
Oberc MA, Engel WK:  Ultrastructural localization of calcium in normal and abnormal skeletal muscle . Lab Invest 36:566-577, 1977;.
147 +
Langer A:  Events at the cardiac sarcolemma location and movement of contractile-dependent calcium . Fed Proc 35:1274-1278, 1976;.
148 +
Hadju S, Leonard EJ:  A calcium transport system for mammalian cells . Life Sci 17:1527-1534, 1975;.
149 +
Schwartz A:  Cell membrane Na-, K+ATPase and sarcoplasmic reticulum: Possible regulators of intracellular ion activity . Fed Proc 35:1279-1282, 1976;.
150 +
Siegel BA, Engel WK, Derrer EC:  Localization of 99mTc-diphosphonate in acutely injured muscle: Relationship to muscle calcium deposition . Neurology 25:1055-1058, 1975;.
151 +
Siegel BA, Engel WK, Derrer EC:  Localization of technetium 99mdiphosphonate in acutely injured muscle . Neurology 27:230-238, 1977;.
152 +
Brumback RA, Bertorini TE, Engel WK, et al:  The effect of pharmacologic acetylcholine receptor blockade on fibrilation and myotonic in rat skeletal muscle . Arch Neurol 35:8-10, 1978;.
153 +
Kula R, Line BR, Siegel BA, et al:  99mTc-diphosphonate scanning of soft-tissue in neuromuscular diseases . Neurology 26:370, 1976;.
154 +
Askanas V:  Identification of the agent responsible for the abnormal immunoelectrophoretic pattern of serum in Duchenne's progressive muscular dystrophy . Life Sci 5:1767-1773, 1966;.
155 +
Askanas V:  Immunoelectrophoretic study of sera of patients with Duchenne's progressive muscular dystrophy . Neurol Neurochir Pol 1:141-146, 1967;.
156 +
Askanas V, Engel WK:  Chick muscle in tissue culture: The ubiquity of viral infection . Acta Neuropathol 32:271-279, 1975;.
157 +
Askanas V, Engel WK, Britton DE, et al:  Reincarnation in cultured muscle of mitochondrial abnormalities from two patients with epilepsy and lactic-acidosis . Arch Neurol , to be published.
158 +
Askanas V, Mazurczak J:  The serum immunoelectrophoretic test in patients with Duchenne's progressive muscular dystrophy . Life Sci 5:247-251, 1966;.
159 +
Danieli GA, Angelini C:  Duchenne carrier detection . Lancet 2:90, 1976;.
160 +
Danieli GA, Angelini C:  Duchenne carrier detection . Lancet 2:415, 1976;.
161 +
Carafoli E:  The transport of Ca++ by mitochondria. Problems and perspectives . Biochemie 55:755-762, 1973;.
162 +
Carafoli E, Patriarcha P, Rossi CS:  A comparative study of the role of mitochondria and the sarcoplasmic reticulum in the uptake and release of Ca++ by the rat diaphragm . J Cell Physiol 74:17-30, 1969;.
163 +
Jacobus WE, Tiozzo R, Lugli G, et al:  Aspects of energy-linked calcium accumulation by rat heart mitochondria . J Biol Chem 250:7863-7870, 1975;.
164 +
Meissner G:  ATP and Ca+ + binding by the Ca++ pump protein of sarcoplasmic reticulum . Biochim Biophys Acta 298:906-926, 1973;.
165 +
Bianchi CP:  Cell calcium and malignant hyperthermia , in Gordon RA, Britt BA, Kalow W (eds): Malignant Hyperthermia . Springfield, Ill, Charles C Thomas Publisher, 1973;, pp 147-151.
166 +
Moore L, Chen T, Knapp HR, et al:  Energy-dependent calcium sequestration activity in rat liver microsomes . J Biol Chem 250:4562-4568, 1975;.
167 +
Yu BP, Masoro EJ, Morley TF:  Analysis of the arrangement of protein components in the sarcoplasmic reticulum of rat skeletal muscle . J Biol Chem 251:2037-2043, 1976;.
168 +
MacLennan DH:  Components of the calcium transport system of sarcoplasmic reticulum , in Gordon RA, Britt BA, Kalow W (eds): Malignant Hyperthermia . Springfield, Ill, Charles C Thomas Publisher, 1976;, pp 139-146.
169 +
Gilbert DS, Newley BJ, Anderton BH:  Neurofilament disguise, destruction and discipline . Nature 256:586, 1975;.
170 +
Reddy MK, Etlinger JD, Rabinowitz M, et al:  Removal of Z-lines and α-actinin from isolated myofibrils by a calcium-activated neutral protease . J Biol Chem 250:4278-4284.
171 +
Reville WJ, Goll DE, Stromer MH, et al:  A Ca++-activated protease possibly involved in myofibrillar protein turnover: Subcellular localization of the protease in porcine skeletal muscle . J Cell Biol 70:1-8, 1976;.
172 +
Roobel A, Alleyne GAO:  A study of stabilization of glucoeogenic activity in rat live slices by calcium and manganese ions . Biochem J 129:231-239, 1972;.
173 +
Gazitt Y, Ohad J, Layter A:  Changes in phospholipid susceptibility toward phospholypases in ATP depletion in avian and amphibian erythrocyte membranes . Biochim Biophys Acta 382:65-72, 1975;.
174 +
Nicholson G, Paste A:  The cancer cell: Dynamic aspects and modifications in cellsurface organization . N Engl J Med 295:197-203, 1976;.
175 +
Hinkley RE, Green LS:  Effects of halothane and colchicine on microtubules and electrical activity of rabbit vagus nerves . J Neurobiol 2:97, 1971;.
176 +
Samson FE, Hinkley RE:  Neuronal microtubular systems (editorial views) . Anesthesiology 36:417, 1972;.
177 +
Schlaepfer W, Bingg R:  High Ca++ solution for Wallerian degeneration . J Cell Biol 59:456, 1973;.
178 +
Darzynkiewicz A, Traganos F, Sharpless T, et al:  DNA denaturation in situ . J Cell Biol 68:1-10, 1976;.
179 +
Comings DE, Harris DC:  Nuclear proteins: I. Electrophoretic comparison of mouse nucleoli, heterochromatin, euchromatin and contractile proteins . Exp Cell Res 96:161-179, 1975;.
180 +
Engel WK, Cunningham GG:  Alkaline phosphatase-positive abnormal muscle fibers of humans . J Histochem Cytochem 18:55-57, 1970;.
181 +
Hawley RJ, Engel WK:  Focal lesions of muscle in peripheral vascular disease: Their comparison with Duchenne muscular dystrophy . Trans Am Neurol Assoc 101:240-242, 1976;.
182 +
Gordon RA, Britt BA, Kalow W: Malignant Hyperthermia . Springfield, Ill, Charles C Thomas Publisher, 1973;.

Correspondence

Submit a Letter
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

© 2012 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems